PlainRecalls
FDA Drug Moderate Class II Ongoing

LOSARTAN POTASSIUM 50 mg TABLET BULK 90 count bottles and 1000 count bottles, NDC 00591-3746-00

Reported: July 17, 2019 Initiated: June 6, 2019 #D-1455-2019

Product Description

LOSARTAN POTASSIUM 50 mg TABLET BULK 90 count bottles and 1000 count bottles, NDC 00591-3746-00

Reason for Recall

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
2,924,000 tablets
Distribution
Nationwide by 4 major distributors.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
LOSARTAN POTASSIUM 50 mg TABLET BULK 90 count bottles and 1000 count bottles, NDC 00591-3746-00. Recalled by Teva Pharmaceuticals USA. Units affected: 2,924,000 tablets.
Why was this product recalled?
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 17, 2019. Severity: Moderate. Recall number: D-1455-2019.